1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Aliskiren and hydrochlorothiazide
Trade Name:
Rasilez HCT
Manufacturer/Distributor:
Novartis
www.novartis.ca, 1-800-363-8883
Classification:
Renin inhibitor and diuretic
ATC Class:
C09XA52 Aliskiren and hydrochlorothiazide
Status:
active
Notice of Compliance (yyyy/mm/dd):
2009/09/04
Date Marketed in Canada (yyyy/mm/dd):
2009/09
Presentation:
Tablet: aliskiren 150 mg + hydrochlorothiazide 12.5 mg; DIN 02332728
Tablet: aliskiren 150 mg + hydrochlorothiazide 25 mg; DIN 02332736
Tablet: aliskiren 300 mg + hydrochlorothiazide 12.5 mg; DIN 02332744
Tablet: aliskiren 300 mg + hydrochlorothiazide 25 mg; DIN 02332752
Comments:
For mild to moderate essential hypertension in patients for whom combination therapy is appropriate. Not indicated for initial therapy.
Back to:
Drug Product Listings 
